Chronic kidney disease (CKD) and atherosclerotic cardiovascular disease (ASCVD) are closely intertwined, sharing systemic inflammation as a key driver of disease progression and adverse outcomes. As evidence continues to evolve, understanding and targeting inflammation is increasingly becoming a critical component of comprehensive care for patients living with CKD who are at heightened cardiovascular risk.
This interactive digital clinical bulletin is designed to bring busy healthcare professionals up to speed on the latest research, expert guidance, and practical strategies for addressing systemic inflammation in the context of CKD and ASCVD risk. Explore how inflammation links CKD and ASCVD, and why it represents a critical—and modifiable—therapeutic target.
This digital clinical bulletin is eligible for free continuing education credit!
To claim up to 0.5 hours of CME/CE credit (includes 0.25 contact hours in the area of pharmacology) for this program, visit the NKF Professional Education Resource Center (PERC) to register and complete the requirements. Credit available until August 15, 2026.
Connect with Us
For Kidney Health Professionals Who Want to Stay Informed
Opt in to receive education opportunities for professionals, resources for your patients, or updates from NKF.